NRG Oncology
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2014-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.nrgoncology.org
Comparing Radiation Therapy to Usual Care for Patients With High-Risk Bone Asymptomatic Metastases
Phase 3
Not yet recruiting
- Conditions
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 280
- Registration Number
- NCT06745024
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3
Not yet recruiting
- Conditions
- Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube High Grade Serous AdenocarcinomaFIGO Stage III Ovarian Cancer 2014FIGO Stage IV Ovarian Cancer 2014Ovarian CarcinomaPrimary Peritoneal Endometrioid AdenocarcinomaPrimary Peritoneal High Grade Serous AdenocarcinomaOvarian High Grade Serous Adenocarcinoma
- Interventions
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2024-08-30
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 880
- Registration Number
- NCT06580314
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Phase 2
Not yet recruiting
- Conditions
- Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Head and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell CarcinomaNasopharyngeal Squamous Cell CarcinomaOral Cavity Squamous Cell CarcinomaOropharyngeal Squamous Cell CarcinomaStage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
- Interventions
- Other: Best PracticeProcedure: Biospecimen CollectionDrug: CisplatinProcedure: Computed TomographyRadiation: Image Guided Radiation TherapyRadiation: Intensity-Modulated Radiation TherapyProcedure: Magnetic Resonance ImagingDrug: Placebo AdministrationDrug: MnSOD Mimetic BMX-001Other: Questionnaire Administration
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 98
- Registration Number
- NCT06532279
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Phase 3
Recruiting
- Conditions
- Metastatic Breast CarcinomaMetastatic Malignant Solid NeoplasmAnatomic Stage IV Breast Cancer AJCC v8Metastatic Digestive System CarcinomaStage IV Renal Cell Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic MelanomaMetastatic Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Metastatic Malignant Neoplasm in the Brain
- Interventions
- First Posted Date
- 2024-07-15
- Last Posted Date
- 2024-11-29
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 269
- Registration Number
- NCT06500455
- Locations
- 🇺🇸
Banner University Medical Center - Tucson, Tucson, Arizona, United States
🇺🇸University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States
🇺🇸City of Hope Comprehensive Cancer Center, Duarte, California, United States
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Phase 3
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-15
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 115
- Registration Number
- NCT06500481
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-29
- Last Posted Date
- 2024-07-15
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 325
- Registration Number
- NCT06388018
- Locations
- 🇺🇸
Women and Infants Hospital, Providence, Rhode Island, United States
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
- First Posted Date
- 2024-02-26
- Last Posted Date
- 2024-11-28
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 516
- Registration Number
- NCT06279013
- Locations
- 🇺🇸
Cancer Center at Saint Joseph's, Phoenix, Arizona, United States
🇺🇸Augusta University Medical Center, Augusta, Georgia, United States
🇺🇸John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-07-14
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 1209
- Registration Number
- NCT05946213
- Locations
- 🇺🇸
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸Lewis and Faye Manderson Cancer Center, Tuscaloosa, Alabama, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors
Not Applicable
Recruiting
- Conditions
- First Posted Date
- 2023-06-09
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 386
- Registration Number
- NCT05896189
- Locations
- 🇺🇸
Washington Hospital, Fremont, California, United States
🇺🇸UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, United States
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-05-30
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- NRG Oncology
- Target Recruit Count
- 3960
- Registration Number
- NCT05879926
- Locations
- 🇺🇸
The Don and Sybil Harrington Cancer Center, Amarillo, Texas, United States
🇺🇸UTMB Health Angleton Danbury Campus, Angleton, Texas, United States
🇺🇸MD Anderson in The Woodlands, Conroe, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath